Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STE · against 1,336 other Healthcare companies
Ranked #462 of 1,337 · scores higher than 65% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 60–69, including STE · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | STE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 3.5% | 1.5% | 66% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 6.8% | 4.2% | 66% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 4.1% | -1.0% | 75% | 20% | |
| Book yieldHigher is better · 1,306 reported | 31.9% | 37.9% | 42% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 462 | 679.6B INR (≈$8.2B) | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 77 |
| 462 | 51.2B INR (≈$614M) | 65 | 63 |
| 462 | 6.6B USD | 65 | 61 |
| 462 | 12.7B AUD (≈$8.4B) | 65 | 38 |
| 462 | 22.6B USD | 65 | 59 |
| 462 | 3.0B SEK (≈$301M) | 65 | 56 |
| 462 | 363.0B USD | 65 | 47 |
| 476 | 7.9B CNY (≈$1.1B) | 64 | 64 |
| 476 | 3.9B CNY (≈$543M) | 64 | 48 |